74-week follow-up of safety of infliximab in patients with refractory rheumatoid arthritis

Por Delabaye, Isabelle, De Keyser, Filip
Publicado em 2010

Assessment of Activity Limitations with the Health Assessment Questionnaire Predicts the Need for Support Measures in Patients with Rheumatoid Arthritis: A Multicenter Observationa...

Por Janssens, Xavier, Decuman, Saskia, De Keyser, Filip
Publicado em 2014

Comparison of the Belgian Rheumatoid Arthritis Disability Assessment and Health Assessment Questionnaires as Tools to Predict the Need for Support Measures in Patients with Rheumat...

Por Janssens, Xavier, Decuman, Saskia, De Keyser, Filip
Publicado no PLoS One (2016)

Seven-year follow-up of infliximab therapy in rheumatoid arthritis patients with severe long-standing refractory disease: attrition rate and evolution of disease activity

Por Vander Cruyssen, Bert, Durez, Patrick, Westhovens, Rene, De Keyser, Filip
Publicado em 2010

Tumor necrosis factor-α blockade in ankylosing spondylitis: a potent but expensive anti-inflammatory treatment or true disease modification?

Por Van den Bosch, Filip, De Keyser, Filip, Mielants, Herman, Veys, Eric M
Publicado em 2005

Response to the commentary 'Pooled indices to measure rheumatoid arthritis activity: a good reflection of the physician's mind'

Por Vander Cruyssen, Bert, Durez, Patrick, Westhovens, Rene, Vastesaeger, Nathan, Geldhof, Anja, De Keyser, Filip
Publicado em 2006

Histopathological cutaneous alterations in systemic sclerosis: a clinicopathological study

Por Van Praet, Jens T, Smith, Vanessa, Haspeslagh, Marc, Degryse, Nele, Elewaut, Dirk, De Keyser, Filip
Publicado em 2011

The Belgian MIRA (MabThera In Rheumatoid Arthritis) registry: clues for the optimization of rituximab treatment strategies

Por Vander Cruyssen, Bert, Durez, Patrick, Westhovens, Rene, Kaiser, Marie-Joelle, Hoffman, Ilse, De Keyser, Filip
Publicado em 2010

Citrullinated vimentin as an important antigen in immune complexes from synovial fluid of rheumatoid arthritis patients with antibodies against citrullinated proteins

Por Van Steendam, Katleen, Tilleman, Kelly, De Ceuleneer, Marlies, De Keyser, Filip, Elewaut, Dirk, Deforce, Dieter
Publicado em 2010

Quantification of IFNγ- and IL17-producing cells after stimulation with citrullinated proteins in healthy subjects and RA patients

Por Van Steendam, Katleen, De Ceuleneer, Marlies, Tilleman, Kelly, Elewaut, Dirk, De Keyser, Filip, Deforce, Dieter
Publicado em 2012

Infiltration of the synovial membrane with macrophage subsets and polymorphonuclear cells reflects global disease activity in spondyloarthropathy

Por Baeten, Dominique, Kruithof, Elli, De Rycke, Leen, Boots, Anemieke M, Mielants, Herman, Veys, Eric M, De Keyser, Filip
Publicado em 2005

Prediction models for rheumatoid arthritis during diagnostic investigation: evaluation of combinations of rheumatoid factor, anti‐citrullinated protein/peptide antibodies and the h...

Por Cruyssen, Bert Vander, Hoffman, Ilse E A, Peene, Isabelle, Union, Ann, Mielants, Herman, Meheus, Lydie, De Keyser, Filip
Publicado em 2007

Effects of intra‐articular corticosteroids and anti‐TNF therapy on neutrophil activation in rheumatoid arthritis

Por Wittkowski*, Helmut, Foell*, Dirk, Klint, Erik af, De Rycke, Leen, De Keyser, Filip, Frosch, Michael, Ulfgren, Ann‐Kristin, Roth, Johannes
Publicado em 2007

Vaccinations in patients with immune-mediated inflammatory diseases

Por Rahier, Jean-François, Moutschen, Michel, Van Gompel, Alfons, Van Ranst, Marc, Louis, Edouard, Segaert, Siegfried, Masson, Pierre, De Keyser, Filip
Publicado em 2010

Rheumatoid arthritis and pregnancy: evolution of disease activity and pathophysiological considerations for drug use

Por Hazes, Johanna M.W., Coulie, Pierre G., Geenen, Vincent, Vermeire, Séverine, Carbonnel, Franck, Louis, Edouard, Masson, Pierre, De Keyser, Filip
Publicado em 2011

Synovial histopathology of psoriatic arthritis, both oligo- and polyarticular, resembles spondyloarthropathy more than it does rheumatoid arthritis

Por Kruithof, Elli, Baeten, Dominique, De Rycke, Leen, Vandooren, Bernard, Foell, Dirk, Roth, Johannes, Cañete, Juan D, Boots, Annemieke M, Veys, Eric M, De Keyser, Filip
Publicado em 2005

Diagnostic value of anti-human citrullinated fibrinogen ELISA and comparison with four other anti-citrullinated protein assays

Por Vander Cruyssen, Bert, Cantaert, Tineke, Nogueira, Leonor, Clavel, Cyril, De Rycke, Leen, Dendoven, Amélie, Sebag, Mireille, Deforce, Dieter, Vincent, Christian, Elewaut, Dirk, Serre, Guy, De Keyser, Filip
Publicado em 2006

Cancer risk in immune-mediated inflammatory diseases (IMID)

Por Beyaert, Rudi, Beaugerie, Laurent, Van Assche, Gert, Brochez, Lieve, Renauld, Jean-Christophe, Viguier, Manuelle, Cocquyt, Veronique, Jerusalem, Guy, Machiels, Jean-Pascal, Prenen, Hans, Masson, Pierre, Louis, Edouard, De Keyser, Filip
Publicado em 2013

Four-year follow-up of infliximab therapy in rheumatoid arthritis patients with long-standing refractory disease: attrition and long-term evolution of disease activity

Por Cruyssen, Bert Vander, Van Looy, Stijn, Wyns, Bart, Westhovens, Rene, Durez, Patrick, Van den Bosch, Filip, Mielants, Herman, De Clerck, Luc, Peretz, Ann, Malaise, Michel, Verbruggen, Leon, Vastesaeger, Nathan, Geldhof, Anja, Boullart, Luc, De Keyser, Filip
Publicado em 2006

DAS28 best reflects the physician's clinical judgment of response to infliximab therapy in rheumatoid arthritis patients: validation of the DAS28 score in patients under infliximab...

Por Vander Cruyssen, Bert, Van Looy, Stijn, Wyns, Bart, Westhovens, Rene, Durez, Patrick, Van den Bosch, Filip, Veys, Eric M, Mielants, Herman, De Clerck, Luc, Peretz, Anne, Malaise, Michel, Verbruggen, Leon, Vastesaeger, Nathan, Geldhof, Anja, Boullart, Luc, De Keyser, Filip
Publicado em 2005